Neurodegenerative diseases in children

Area of Science:

• Pediatric Neurology
• Metabolic Disorders
• Neurodegenerative Diseases

Background:

• Childhood neurodegenerative and neurometabolic diseases often mimic common pediatric issues like vomiting or developmental delay.
• Presentation can range from acute encephalopathy to chronic progressive neurological decline.
• A high index of suspicion is essential for timely diagnosis.

Purpose of the Study:

• To outline the diagnostic approach for neurodegenerative and neurometabolic diseases in children.
• To highlight key clinical clues and initial screening tests.
• To emphasize the importance of accurate diagnosis for treatment and genetic counseling.

Main Methods:

• Clinical assessment focusing on encephalopathic features (e.g., seizures, hypotonia, abnormal eye signs) and systemic signs (e.g., hepatosplenomegaly, liver dysfunction).
• Initial laboratory screening for metabolic derangements like acidosis, ketosis, hyperlacticemia, and hyperammonemia.
• Further investigations including amino acid chromatography, organic acid assays, enzyme assays, and tissue biopsies.

Main Results:

• Clinical clues are diverse, encompassing neurological and systemic manifestations.
• Initial screening identifies metabolic abnormalities.
• Advanced biochemical and histopathological analyses are necessary for definitive diagnosis.

Conclusions:

• Prompt recognition of subtle clinical signs is critical for identifying these rare conditions in children.
• A systematic diagnostic pathway, from initial screening to specialized testing, is vital.
• Accurate diagnosis enables targeted interventions, genetic counseling, and potential prenatal diagnosis, improving patient outcomes.